Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Pharmaids Pharmaceuticals Financial Results

Pharmaids Pharmaceuticals reported audited FY26 results and approved a ₹0.75 Crore corporate guarantee for its subsidiary. Performance details and subsidiary support reflect ongoing operational strategy.

Key figures
Value₹0.75 Cr
Source

BSE filing, NSE: PHARMAID. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Pharmaids Pharmaceuticals Ltd: key numbers

Share price
₹27.52
Market cap
₹97.06 Cr
Revenue (annual)
₹27.88 Cr
Net profit (annual)
₹-11.72 Cr
P/E (TTM)
-21.3×Sector 46.1×
Promoter holding
32.99%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Pharmaids Pharmaceuticals Ltd

All →

Other financial results announcements

All →